Pharming Announces GRAS Filing On Human Lactoferrin

Pharming Announces GRAS Filing On Human Lactoferrin Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. FSA Receives Plant sterols application DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Database for New Dietary Ingredient Notifications Launches The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China. Bi-national Food Agency Wants Comment on Proposed Changes to Regulations Food Standards Australia New Zealand (FSANZ) has published proposed changes to the Australia New Zealand Food Standards Code including regulations dealing with nutrition, health and related claims and use of an intense sweetener in food. Bi-national Food Agency Wants Comment on Proposed Changes to Regulations Food Standards Australia New Zealand (FSANZ) has published proposed changes to the Australia New Zealand Food Standards Code including regulations dealing with nutrition, health and related claims and use of an intense sweetener in food. FDA Acts to Seize Ephedra-Containing Dietary Supplements The U.S. Attorney's Office for the Eastern District of Texas and the U.S. Attorney's Office for the District of Oregon filed Complaints for Forfeiture against Nature's Treat Energy Plus #1, a dietary supplement that contains ephedra, an herbal source of ephedrine alkaloids. The supplement is distributed by Nature's Treat, Inc., Gainesville, Texas and ACD Distributing, LLC, of Eugene, Oregon. FDA Acts to Seize Ephedra-Containing Dietary Supplements The U.S. Attorney's Office for the Eastern District of Texas and the U.S. Attorney's Office for the District of Oregon filed Complaints for Forfeiture against Nature's Treat Energy Plus #1, a dietary supplement that contains ephedra, an herbal source of ephedrine alkaloids. The supplement is distributed by Nature's Treat, Inc., Gainesville, Texas and ACD Distributing, LLC, of Eugene, Oregon. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Ontario Government Regulating Traditional Chinese Medicine Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility. Canada: Proposed Amendments to Schedule A Claims Rules Published in Canada Gazette, Part 1 The proposed amendments would allow natural health products to make schedule A health claims, currently prohibited under the Food and Drugs Act (subsections 3(1) and 3(2)). Canada: Proposed Amendments to Schedule A Claims Rules Published in Canada Gazette, Part 1 The proposed amendments would allow natural health products to make schedule A health claims, currently prohibited under the Food and Drugs Act (subsections 3(1) and 3(2)). Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. FDA Acts to Protect Public from Fraudulent Avian Flu Therapies Agency has issued warning letters recently to nine companies marketing bogus flu products behind claims that their products could be effective against preventing the avian flu or other forms of influenza. FDA Acts to Protect Public from Fraudulent Avian Flu Therapies Agency has issued warning letters recently to nine companies marketing bogus flu products behind claims that their products could be effective against preventing the avian flu or other forms of influenza. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. FDA to Require Food Manufacturers to List Food Allergens Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods. Canada- Recall of Chaparral-Containing Products Health Canada and the Canadian Food Inspection Agency have issued an advisory recommending that consumers not use oral products conatining chaparral because of serious health concerns. Canada- Recall of Chaparral-Containing Products Health Canada and the Canadian Food Inspection Agency have issued an advisory recommending that consumers not use oral products conatining chaparral because of serious health concerns. Direct Response Marketer Banned A. Glenn Braswell has been banned from the direct response marketing of foods, unapproved drugs, and dietary supplements. Direct Response Marketer Banned A. Glenn Braswell has been banned from the direct response marketing of foods, unapproved drugs, and dietary supplements. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. LycoRed Receives FDA Approval for Food Coloring Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods. FDA Requests Seizure of More Dietary Supplements Containing Ephedrine Alkaloids The U.S. Attorney's Office for the Western District of Pennsylvania has filed a Complaint for Forfeiture against Lipodrene, a dietary supplement that contains ephedrine alkaloids, seizing product valued at approximately $16,000 at ATF Fitness Products, Inc., in Oakmont, PA. FDA Requests Seizure of More Dietary Supplements Containing Ephedrine Alkaloids The U.S. Attorney's Office for the Western District of Pennsylvania has filed a Complaint for Forfeiture against Lipodrene, a dietary supplement that contains ephedrine alkaloids, seizing product valued at approximately $16,000 at ATF Fitness Products, Inc., in Oakmont, PA. FDA Warns Consumers about Brazilian Diet Pills Found to Contain Active Drug Ingredients FDA is warning consumers not to use two unapproved drug products (Emagrece Sim Dietary Supplement, also known as the Brazilian Diet Pill and Herbathin Dietary Supplement) that are being marketed as dietary supplements for weight loss, as they may contain ingreidents, including controlled substances, that could lead to serious side effects or injury. FDA Warns Consumers about Brazilian Diet Pills Found to Contain Active Drug Ingredients FDA is warning consumers not to use two unapproved drug products (Emagrece Sim Dietary Supplement, also known as the Brazilian Diet Pill and Herbathin Dietary Supplement) that are being marketed as dietary supplements for weight loss, as they may contain ingreidents, including controlled substances, that could lead to serious side effects or injury. NNFA Files Health Claims Comments NNFA recently submitted comments to the Food and Drug Administration (FDA) regarding health claims on product labels noting that manufacturers report that current FDA standards for health claim language is cumbersome and even conflicting. NNFA Files Health Claims Comments NNFA recently submitted comments to the Food and Drug Administration (FDA) regarding health claims on product labels noting that manufacturers report that current FDA standards for health claim language is cumbersome and even conflicting. Navamedic Obtains Glucosamine HCl Product Approval in 19 European Countries Navamedic's glucosamine HCl product has been approved in 19 countries for treatment of osteoarthritis of the knee. The product was approved in Sweden in August 2005, and has now been reviewed in the European Mutual Recognition Procedure. Navamedic Obtains Glucosamine HCl Product Approval in 19 European Countries Navamedic's glucosamine HCl product has been approved in 19 countries for treatment of osteoarthritis of the knee. The product was approved in Sweden in August 2005, and has now been reviewed in the European Mutual Recognition Procedure. Navamedic Obtains Glucosamine HCl Product Approval in 19 European Countries Navamedic's glucosamine HCl product has been approved in 19 countries for treatment of osteoarthritis of the knee. The product was approved in Sweden in August 2005, and has now been reviewed in the European Mutual Recognition Procedure. Navamedic Obtains Glucosamine HCl Product Approval in 19 European Countries Navamedic's glucosamine HCl product has been approved in 19 countries for treatment of osteoarthritis of the knee. The product was approved in Sweden in August 2005, and has now been reviewed in the European Mutual Recognition Procedure. Navamedic Obtains Glucosamine HCl Product Approval in 19 European Countries Navamedic's glucosamine HCl product has been approved in 19 countries for treatment of osteoarthritis of the knee. The product was approved in Sweden in August 2005, and has now been reviewed in the European Mutual Recognition Procedure. Navamedic Obtains Glucosamine HCl Product Approval in 19 European Countries Navamedic's glucosamine HCl product has been approved in 19 countries for treatment of osteoarthritis of the knee. The product was approved in Sweden in August 2005, and has now been reviewed in the European Mutual Recognition Procedure. AHPA Expresses Support for National Uniformity in Labeling Legislation AHPA’s Executive Committee has voted unanimously to support legislation currently pending in the U.S. House of Representatives that would generally prohibit individual states from requiring food products in interstate trade, including dietary supplements, to conform to state regulations or labeling rules that are not identical to federal provisions. AHPA Expresses Support for National Uniformity in Labeling Legislation AHPA’s Executive Committee has voted unanimously to support legislation currently pending in the U.S. House of Representatives that would generally prohibit individual states from requiring food products in interstate trade, including dietary supplements, to conform to state regulations or labeling rules that are not identical to federal provisions. AHPA Tele-Seminar Focuses on Supplement Claim Substantiation as Feds Step Up Enforcement upcoming tele-seminar, Substantiation for Dietary Supplements — How to Ensure Dietary Supplement Product Claims Are Truthful, Legal & Documented, will supply advice from a panel of experts who are actively involved in all aspects of claim substantiation for dietary supplements - Friday, March 3 at 1:00 pm ET, running approximately two hours. AHPA Tele-Seminar Focuses on Supplement Claim Substantiation as Feds Step Up Enforcement upcoming tele-seminar, Substantiation for Dietary Supplements — How to Ensure Dietary Supplement Product Claims Are Truthful, Legal & Documented, will supply advice from a panel of experts who are actively involved in all aspects of claim substantiation for dietary supplements - Friday, March 3 at 1:00 pm ET, running approximately two hours. AHPA Tele-Seminar Focuses on Supplement Claim Substantiation as Feds Step Up Enforcement upcoming tele-seminar, Substantiation for Dietary Supplements — How to Ensure Dietary Supplement Product Claims Are Truthful, Legal & Documented, will supply advice from a panel of experts who are actively involved in all aspects of claim substantiation for dietary supplements - Friday, March 3 at 1:00 pm ET, running approximately two hours. AHPA Tele-Seminar Focuses on Supplement Claim Substantiation as Feds Step Up Enforcement upcoming tele-seminar, Substantiation for Dietary Supplements — How to Ensure Dietary Supplement Product Claims Are Truthful, Legal & Documented, will supply advice from a panel of experts who are actively involved in all aspects of claim substantiation for dietary supplements - Friday, March 3 at 1:00 pm ET, running approximately two hours. Natural health product Libidfit may pose health risks Health Canada is warning consumers not to use the natural health product Libidfit because it has been found to contain an undeclared ingredient, similar to sildenafil, that could lead to serious health risks, especially for patients with existing medical conditions such as heart problems. Natural health product Libidfit may pose health risks Health Canada is warning consumers not to use the natural health product Libidfit because it has been found to contain an undeclared ingredient, similar to sildenafil, that could lead to serious health risks, especially for patients with existing medical conditions such as heart problems. Dietary Supplement Ad Creator Settles FTC Charges The creator of allegedly false and misleading advertising for Gero Vita International’s dietary supplements, Chase Revel, has settled Federal Trade Commission charges and will be required to post a $1 million performance bond before advertising, marketing, or selling any food, drug, dietary supplement, device, or health-related service. Dietary Supplement Ad Creator Settles FTC Charges The creator of allegedly false and misleading advertising for Gero Vita International’s dietary supplements, Chase Revel, has settled Federal Trade Commission charges and will be required to post a $1 million performance bond before advertising, marketing, or selling any food, drug, dietary supplement, device, or health-related service. McGuffin Presents Industry View at FWS Ginseng Meeting U.S. Fish and Wildlife Service (FWS) yesterday held the first of three public meetings that it has scheduled to discuss the Federal regulatory framework for the export of wild and cultivated American ginseng, with close to 100 people attending. AHPA President Michael McGuffin spoke at this meeting. McGuffin Presents Industry View at FWS Ginseng Meeting U.S. Fish and Wildlife Service (FWS) yesterday held the first of three public meetings that it has scheduled to discuss the Federal regulatory framework for the export of wild and cultivated American ginseng, with close to 100 people attending. AHPA President Michael McGuffin spoke at this meeting. McGuffin Presents Industry View at FWS Ginseng Meeting U.S. Fish and Wildlife Service (FWS) yesterday held the first of three public meetings that it has scheduled to discuss the Federal regulatory framework for the export of wild and cultivated American ginseng, with close to 100 people attending. AHPA President Michael McGuffin spoke at this meeting. McGuffin Presents Industry View at FWS Ginseng Meeting U.S. Fish and Wildlife Service (FWS) yesterday held the first of three public meetings that it has scheduled to discuss the Federal regulatory framework for the export of wild and cultivated American ginseng, with close to 100 people attending. AHPA President Michael McGuffin spoke at this meeting. Cantox and Others Host US and EU Legal and Claims Comparative Analysis Workshop CANTOX, along with Law firms (Coutrelis & Associes and Hyman, Phelps & McNamara, PC) will be hosting a workshop on Tuesday, April 4, 2006 in Washington, DC, to provide a comparative analysis of the current US and EU legal frameworks and scientific health claim substantiation standards. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009 NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009 Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.	Leiden, The Netherlands, December 29, 2005. Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that it has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA). Pharming has notified the FDA that its hLF is generally recognized as safe for use as an ingredient in functional foods. Pharming's hLF GRAS notification has been reviewed by an independent scientific expert panel. After careful evaluation of numerous safety studies performed with Pharming's hLF as well as of published scientific data, the expert panel has concluded that hLF is safe for its intended uses. "Pharming is pleased with the progress on the development of hLF," said Dr. Francis Pinto, CEO of Pharming. "The Company is in a strong position to execute commercial agreements and is ready for a new phase of rapid corporate growth." Background on Pharming Group N.V. Pharming Group N.V. is developing innovative protein products for unmet needs. The Company's products include potential treatments for genetic disorders, specialty products for surgical indications, intermediates for various applications and food products. Pharming has two products in late stage development - recombinant human C1 inhibitor for hereditary angioedema (Phase III) and recombinant human lactoferrin for use in functional foods. The advanced technologies of the Company include innovative platforms for the production of protein therapeutics, as well as technology and processes for the purification and formulation of these products. Additional information is available on the Pharming website, http://www.pharming.com. This press release contains forward looking statements that involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the results, performance or achievements expressed or implied by these forward looking statements. The press release also appears in Dutch. In the event of any inconsistency, the English version will prevail over the Dutch version.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software